SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-11-012496
Filing Date
2011-03-03
Accepted
2011-03-03 06:04:30
Documents
3
Group Members
MANGROVE CAPITALMANGROVE PARTNERSNATHANIEL AUGUST

Document Format Files

Seq Description Document Type Size
1 v213293_sc13d-a.htm SC 13D/A 107927
2 v213293_ex99-1.htm EX-99.1 553030
3 GRAPHIC logo.jpg GRAPHIC 3658
  Complete submission text file 0001144204-11-012496.txt   668108
Mailing Address 2 HOLLAND WAY EXETER NH 03833
Business Address 2 HOLLAND WAY EXETER NH 03833 (603) 658-6100
CPEX Pharmaceuticals, Inc. (Subject) CIK: 0001418919 (see all company filings)

IRS No.: 261172076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-84092 | Film No.: 11658348
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 W. 58TH STREET SUITE 8F NEW YORK NY 10019
Business Address 100 W. 58TH STREET SUITE 8F NEW YORK NY 10019 (646) 450-0418
Mangrove Partners Fund, L.P. (Filed by) CIK: 0001486623 (see all company filings)

IRS No.: 272067192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A